Systemic Hemodynamic Atherothrombotic Syndrome and Resonance Hypothesis of Blood Pressure Variability: Triggering Cardiovascular Events.
10.4070/kcj.2016.46.4.456
- Author:
Kazuomi KARIO
1
Author Information
1. Division of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan. kkario@jichi.ac.jp
- Publication Type:Review
- Keywords:
Hypertension;
Masked hypertension;
Blood pressure;
Remote sensing technology
- MeSH:
Arteries;
Blood Pressure*;
Cardiovascular Diseases;
Coronary Artery Disease;
Heart Failure;
Hemodynamics*;
Humans;
Hypertension;
Masked Hypertension;
Phenotype;
Remote Sensing Technology;
Renal Insufficiency, Chronic;
Stroke;
Vascular Diseases
- From:Korean Circulation Journal
2016;46(4):456-467
- CountryRepublic of Korea
- Language:English
-
Abstract:
Blood pressure (BP) exhibits different variabilities and surges with different time phases, from the shortest beat-by-beat to longest yearly changes. We hypothesized that the synergistic resonance of these BP variabilites generates an extraordinarily large dynamic surge in BP and triggers cardiovascular events (the resonance hypothesis). The power of pulses is transmitted to the peripheral sites without attenuation by the large arteries, in individuals with stiffened arteries. Thus, the effect of a BP surge on cardiovascular risk would be especially exaggerated in high-risk patients with vascular disease. Based on this concept, our group recently proposed a new theory of systemic hemodynamic atherothromboltic syndrome (SHATS), a vicious cycle of hemodynamic stress and vascular disease that advances organ damage and triggers cardiovascular disease. Clinical phenotypes of SHATS are large-artery atherothombotic diseases such as stroke, coronary artery disease, and aortic and pheripheral artery disease; small-artery diseases, and microcirculation-related disease such as vascular cognitive dysfunction, heart failure, and chronic kidney disease. The careful consideration of BP variability and vascular diseases such as SHATS, and the early detection and management of SHATS, will achieve more effective individualized cardiovascular protection. In the near future, information and communication technology-based 'anticipation medicine' predicted by the changes of individual BP values could be a promising approach to achieving zero cardiovascular events.
